Litigation Resolved With $775M Settlement for Patients Prescribed Blood Thinner

Pharmacy Times: A settlement has been reached for litigation filed by patients with bleeding injury following the use of a prescription blood thinner.1-2

Bayer Healthcare and Janssen Pharmaceuticals Inc., the makers of the Xarelto® (rivaroxaban), have agreed to pay $775,000,000 to resolve approximately 25,000 state and federal legal claims surrounding the medication.

Read article